Report overview
Pet Veterinary Drug refers to a drug used in the diagnosis, cure, mitigation, treatment or prevention of diseases in pets.
This report aims to provide a comprehensive presentation of the global market for Pet Veterinary Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Veterinary Drug. This report contains market size and forecasts of Pet Veterinary Drug in global, including the following market information:
Global Pet Veterinary Drug Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Pet Veterinary Drug Market Sales, 2018-2023, 2024-2030, (K Units)
Global top five Pet Veterinary Drug companies in 2022 (%)
The global Pet Veterinary Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The global pet veterinary drug market is divided into drugs and biological agents and vaccines according to drugs. According to the ingredients, it is divided into anti-infectives, anti-inflammatory drugs, parasiticides, analgesics and sedatives. Due to the significant growth of the global healthcare industry, global demand for pet veterinary drugs is increasing.
We surveyed the Pet Veterinary Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pet Veterinary Drug Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Pet Veterinary Drug Market Segment Percentages, by Type, 2022 (%)
Anti-Infectives
Anti-Inflammatory
Parasiticides
Analgesics
Sedatives
Others
Global Pet Veterinary Drug Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Pet Veterinary Drug Market Segment Percentages, by Application, 2022 (%)
Veterinary Hospitals
Veterinary Clinics
Drug Stores
Global Pet Veterinary Drug Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Pet Veterinary Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pet Veterinary Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Pet Veterinary Drug revenues share in global market, 2022 (%)
Key companies Pet Veterinary Drug sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Pet Veterinary Drug sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boehringer Ingelheim International GmbH
Zoetis Animal Healthcare
Bayer AG
Merck Animal Health
Elanco Animal Health Inc.
Virbac Group
Ceva
Dechra Pharmaceuticals Plc
Vetoquinol
Orion Corporation
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pet Veterinary Drug, market overview.
Chapter 2: Global Pet Veterinary Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Pet Veterinary Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pet Veterinary Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Pet Veterinary Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
